RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Regulus Therapeutics Stock

Regulus Therapeutics ROA 2024

Regulus Therapeutics ROA

-0.98

Ticker

RGLS

ISIN

US75915K2006

WKN

A2JB9V

In 2024, Regulus Therapeutics's return on assets (ROA) was -0.98, a 61.08% increase from the -0.61 ROA in the previous year.

Regulus Therapeutics Aktienanalyse

What does Regulus Therapeutics do?

Regulus Therapeutics Inc. is a publicly traded biotechnology company specializing in the discovery and development of medicines based on microRNAs (miRNAs). Regulus was founded in 2007 and is headquartered in San Diego, California. Regulus Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Regulus Therapeutics's Return on Assets (ROA)

Regulus Therapeutics's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Regulus Therapeutics's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Regulus Therapeutics's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Regulus Therapeutics’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Regulus Therapeutics stock

What is the Return on Assets (ROA) of Regulus Therapeutics this year?

The Return on Assets (ROA) of Regulus Therapeutics is -0.98 undefined this year.

What was the ROA of Regulus Therapeutics compared to the previous year?

The ROA of Regulus Therapeutics has increased by 61.08% compared to the previous year.

What consequences do high ROA have for investors of Regulus Therapeutics?

A high ROA is advantageous for investors of Regulus Therapeutics, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Regulus Therapeutics?

A low ROA can be unfavorable for investors of Regulus Therapeutics as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Regulus Therapeutics affect the company?

An increase in ROA of Regulus Therapeutics can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Regulus Therapeutics impact the company?

A reduction in the ROA of Regulus Therapeutics can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Regulus Therapeutics?

Some factors that can influence the ROA of Regulus Therapeutics include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Regulus Therapeutics important for investors?

The ROA of Regulus Therapeutics is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Regulus Therapeutics take to improve ROA?

To improve ROA, Regulus Therapeutics can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Regulus Therapeutics pay?

Over the past 12 months, Regulus Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Regulus Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Regulus Therapeutics?

The current dividend yield of Regulus Therapeutics is .

When does Regulus Therapeutics pay dividends?

Regulus Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Regulus Therapeutics?

Regulus Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Regulus Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Regulus Therapeutics located?

Regulus Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Regulus Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Regulus Therapeutics from 9/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Regulus Therapeutics pay the last dividend?

The last dividend was paid out on 9/27/2024.

What was the dividend of Regulus Therapeutics in the year 2023?

In the year 2023, Regulus Therapeutics distributed 0 USD as dividends.

In which currency does Regulus Therapeutics pay out the dividend?

The dividends of Regulus Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Regulus Therapeutics

Our stock analysis for Regulus Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Regulus Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.